Literature DB >> 9157979

Potent pseudosubstrate-based peptide inhibitors for p60(c-src) protein tyrosine kinase.

Q Lou1, M E Leftwich, R T McKay, S E Salmon, L Rychetsky, K S Lam.   

Abstract

We recently reported the identification of GIYWHHY as an efficient and specific substrate for p60(c-src) protein tyrosine kinase (PTK) by screening a secondary random peptide library (Q. Lou et al., Bioorg. Med. Chem., 4: 677-682, 1996). Based on the primary structure of GIYWHHY, we designed and synthesized several pseudosubstrate-based peptide inhibitors. Some of these peptide inhibitors are highly potent and specific with IC50 in the low micromolar range. Because both YIYGSFK and GIYWHHY are efficient and specific substrates for p60(c-src) PTK, chimeric branched peptides based on these two sequences were synthesized. These branched peptides inhibit p60(c-src) PTK with high potency, indicating that the enzyme-active site of p60(c-src) PTK can accommodate more than a linear motif. This may explain why seemingly several peptides with very different linear structures can all be phosphorylated by this enzyme.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9157979

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  2 in total

1.  NaKtide, a Na/K-ATPase-derived peptide Src inhibitor, antagonizes ouabain-activated signal transduction in cultured cells.

Authors:  Zhichuan Li; Ting Cai; Jiang Tian; Joe X Xie; Xiaochen Zhao; Lijun Liu; Joseph I Shapiro; Zijian Xie
Journal:  J Biol Chem       Date:  2009-06-08       Impact factor: 5.157

2.  Rapid Discovery of Functional Small Molecule Ligands against Proteomic Targets through Library-Against-Library Screening.

Authors:  Chun-Yi Wu; Don-Hong Wang; Xiaobing Wang; Seth M Dixon; Liping Meng; Sara Ahadi; Daniel H Enter; Chao-Yu Chen; Jason Kato; Leonardo J Leon; Laura M Ramirez; Yoshiko Maeda; Carolina F Reis; Brianna Ribeiro; Brittany Weems; Hsing-Jien Kung; Kit S Lam
Journal:  ACS Comb Sci       Date:  2016-05-03       Impact factor: 3.784

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.